23.5 Cytotoxic therapy: education for patients on oral cytotoxic drugs

Essential equipment

  • Patient prescription chart
  • Patient information literature

Medicinal products

  • Medication(s) to be supplied to patient

Pre‐procedure

ActionRationale

  1. 1.
    Prior to the first cycle of treatment, check that the appropriate consent procedure has been completed.
    To ensure that the patient gives valid informed consent for treatment (NMC [178], C).
  2. 2.
    Evaluate the patient's knowledge of the oral anticancer medication(s) being administered. Explain the treatment plan to the patient and/or carer. Teaching should include verbal and up‐to‐date written information on the use, action, dose and potential side‐effects of prescribed oral anticancer medication(s).
    To ensure that the patient is fully informed and understands the aim of the treatment and potential adverse effects (DH [48], C; NMC [177], C; NPSA [168], C; van der Molen [259], E; Viele [261], E).
  3. 3.
    Using the counselling checklist, educate patient and/or carer about oral anticancer treatment, including:
    1. How to take their medication(s)
    2. What dose to take
    3. When to take their medication(s) and any breaks in treatment
    4. What to do in the event of omitted doses
    5. What to do if they vomit a dose
    6. When to seek advice about adverse effects
    7. When and who to contact in the event of an emergency
    8. Use of personal protective equipment, safe handling and storage
    9. Disposal of unused oral anticancer medication(s).
    To ensure patients understand that they need to take the correct dose for maximum therapeutic effect. To ensure safety of patient and/or carers. In line with national and local policies (BOPA [16], C; NECN [179], C).
  4. 4.
    Before supplying oral anticancer medication(s) to patient, consult the prescription chart and ascertain that the following are correct:
    1. Medication
    2. Dose
    3. Route
    4. Dates and times of administration
    5. Prescription is correct and legible
    6. Signature of prescriber.
    To ensure the patient is given the correct medications(s) and dose via the correct route at the correct times (NMC [177], C).
    To protect the patient from harm (NMC [178], C).
  5. 5.
    Check the patient's identity by asking them to state their full name and date of birth. If unable to verbally confirm details then check identity wristband against prescription chart.
    To ensure the medication is supplied to the correct patient (NMC [178], C).
  6. 6.
    Obtain a full medication history from the patient and check for potential allergies and drug interactions with oral anticancer medication(s).
    To protect patient from harm (NMC [178], C; Szetela and Gibson [241], E). To prevent unwanted toxicity and therapeutic failure (Goodin [87], C).
  7. 7.
    Assess the patient's ability to take oral anticancer medications in the dosage and form supplied. If any problems with taking medication(s) in prescribed form are identified, provide teaching and written information on crushing or dissolving oral anticancer medication(s) along with any necessary equipment.
    To ensure patient can take prescribed treatment (BOPA [16], C).

Post‐procedure

  1. 8.
    Record and sign that medication(s) have been supplied on the appropriate section on the oral chemotherapy prescription chart.
    To provide a written record that medication has been supplied to patient (NECN [179], C; NMC [178], C; NMC [177]: C).